Notably, the pharmacological stabilization of RyR2-FKBP binding prevented diastolic spontaneous Ca2+ releases in isolated atrial myocytes and decreased the propensity for AF in vivo (Shan et al., 2012). This evidence concerns the gene RYR2 and atrial fibrillation.